|
|
||||||||
lb645 |
Pharmacology, University of Alberta, Edmonton, 0, Canada
ABSTRACT
Reperfusion of the ischemic heart triggers the biosynthesis of reactive oxygen species that damage the myocardium and trigger myocyte apoptosis. Matrix metalloproteinase (MMP)-2 is activated during ischemia-reperfusion injury and mediates contractile dysfunction by proteolyzing novel intracellular targets. We hypothesized that MMP-2 may be a mediator of apoptosis by cleaving Bid. Neonatal rat cardiac myocytes were treated with 200 µM H2O2 +/– MMP inhibitors (50 µM o-phenanthroline or 1 nM tissue inhibitor of metalloproteinase-2). H2O2-induced apoptosis was preceded by early permeabilization of the sarcolemma and reduction in mitochondrial membrane potential; with delayed activation of caspase 3 and DNA fragmentation. MMP inhibitors significantly reduced H2O2-induced apoptotic cell death. H2O2 caused an increase in MMP-2 activity in cell lysates. Incubation of Bid with MMP-2 (4 hr, 37°C) resulted in its cleavage and those cleaved fragments induced cytochrome C release from isolated mitochondria, similar to caspase-8 or calpain cleaved Bid. These data suggest that MMP-2 may be a novel mediator of H2O2-induced apoptotic signalling through proteolytic activation of Bid, a pathway that can be abolished by MMP inhibitors.
| ||||||||||||||||||||||||||||||||||||||||||||